JP2012036221A5 - - Google Patents

Download PDF

Info

Publication number
JP2012036221A5
JP2012036221A5 JP2011244500A JP2011244500A JP2012036221A5 JP 2012036221 A5 JP2012036221 A5 JP 2012036221A5 JP 2011244500 A JP2011244500 A JP 2011244500A JP 2011244500 A JP2011244500 A JP 2011244500A JP 2012036221 A5 JP2012036221 A5 JP 2012036221A5
Authority
JP
Japan
Prior art keywords
formula
compound
salt
solvate
pyridyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011244500A
Other languages
English (en)
Japanese (ja)
Other versions
JP5277303B2 (ja
JP2012036221A (ja
Filing date
Publication date
Priority claimed from DE102004004142A external-priority patent/DE102004004142A1/de
Application filed filed Critical
Publication of JP2012036221A publication Critical patent/JP2012036221A/ja
Publication of JP2012036221A5 publication Critical patent/JP2012036221A5/ja
Application granted granted Critical
Publication of JP5277303B2 publication Critical patent/JP5277303B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2011244500A 2003-05-09 2011-11-08 6−シクリルメチル−および6−アルキルメチル置換ピラゾロピリミジン類 Expired - Lifetime JP5277303B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE10320784 2003-05-09
DE10320784.8 2003-05-09
DE10336183 2003-08-07
DE10336183.9 2003-08-07
DE102004004142A DE102004004142A1 (de) 2003-05-09 2004-01-28 6-Cyclylmethyl- und 6-Alkylmethyl-substituierte Pyrazolopyrimidine
DE102004004142.3 2004-01-28

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006505294A Division JP2006525966A (ja) 2003-05-09 2004-04-28 6−シクリルメチル−および6−アルキルメチル置換ピラゾロピリミジン類

Publications (3)

Publication Number Publication Date
JP2012036221A JP2012036221A (ja) 2012-02-23
JP2012036221A5 true JP2012036221A5 (enExample) 2012-04-05
JP5277303B2 JP5277303B2 (ja) 2013-08-28

Family

ID=33420016

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011244500A Expired - Lifetime JP5277303B2 (ja) 2003-05-09 2011-11-08 6−シクリルメチル−および6−アルキルメチル置換ピラゾロピリミジン類

Country Status (9)

Country Link
EP (1) EP2298773B1 (enExample)
JP (1) JP5277303B2 (enExample)
CL (1) CL2004000978A1 (enExample)
DE (1) DE102004004142A1 (enExample)
MY (1) MY148252A (enExample)
NZ (1) NZ543812A (enExample)
PE (1) PE20050201A1 (enExample)
RU (1) RU2383546C2 (enExample)
TW (1) TWI350836B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2904820C (en) * 2013-04-05 2021-05-18 Eisai R&D Management Co., Ltd. Pyridinylpyrazoloquinoline compound
SG11201909359YA (en) 2017-06-01 2019-11-28 Eisai R&D Man Co Ltd Pharmaceutical composition comprising pde9 inhibitor
WO2018221550A1 (ja) 2017-06-01 2018-12-06 エーザイ・アール・アンド・ディー・マネジメント株式会社 ピラゾロキノリン誘導体とメマンチンの併用による認知症治療剤
JP7269875B2 (ja) 2017-06-01 2023-05-09 エーザイ・アール・アンド・ディー・マネジメント株式会社 ピラゾロキノリン誘導体を含有するレビー小体病治療剤
RU2019135834A (ru) 2017-06-01 2021-07-13 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Терапевтическое средство для лечения деменции, представляющее собой комбинацию производного пиразолохинолина и донепезила

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH396927A (de) 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
DE1147234B (de) 1960-05-11 1963-04-18 Ciba Geigy Verfahren zur Herstellung von 1-Isopropyl-4-hydroxy-6-benzyl-pyrazolo[3, 4-d]pyrimidin
DE1161281B (de) 1960-05-11 1964-01-16 Ciba Aktiengesellschaft, Basel (Schweiz) Verfahren zur Herstellung von 1-Alkyl-6-aralkyl-pyrazoloÄ3,4-dÜ-pyrimidinen.
CH396925A (de) * 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
DE1149013B (de) 1960-05-11 1963-05-22 Ciba Geigy Verfahren zur Herstellung von 4-Oxo-4, 5-dihydro-pyrazolo-[3, 4-d]Pyrimidinen
CH396924A (de) 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung von 4-Mercapto-pyrazolo(3,4-d)pyrimidinen
CH396926A (de) 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
US3732225A (en) 1970-07-23 1973-05-08 Squibb & Sons Inc Pyrazolo(3,4-d)pyrimidine derivatives
US3847908A (en) 1973-03-05 1974-11-12 Squibb & Sons Inc 6-styrylpyrazolo(3,4-d)pyrimidinones and pyrimidines
DE59009485D1 (de) 1989-01-26 1995-09-14 Bayer Ag Optisch aktive (Meth)Acrylsäure-Derivate, ihre Herstellung, ihre Polymerisation zu optisch aktiven Polymeren und deren Verwendung.
RU2104216C1 (ru) * 1994-01-10 1998-02-10 Акционерное общество открытого типа "Таганрогский авиационный научно-технический комплекс им.Г.М.Бериева" Замок
DE19709877A1 (de) 1997-03-11 1998-09-17 Bayer Ag 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
WO2002009713A2 (de) * 2000-08-01 2002-02-07 Bayer Aktiengesellschaft Selektive pde 2-inhibitoren als arzneimittel zur verbesserung der wahrnehmung
HN2002000317A (es) * 2001-11-02 2003-05-21 Pfizer Inhibidores de pde9 para tratamiento de trastornos cardiovasculares
PL370599A1 (en) * 2001-11-02 2005-05-30 Pfizer Products Inc. Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors
DE10219435A1 (de) * 2002-05-02 2003-11-13 Bayer Cropscience Ag Substituierte Pyrazolo-pyrimidin-4-one

Similar Documents

Publication Publication Date Title
JP2017514830A5 (enExample)
JP2013530150A5 (enExample)
JP2010530897A5 (enExample)
JP2013542218A5 (enExample)
JP2009523146A5 (enExample)
JP2013529196A5 (enExample)
JP2012510502A5 (enExample)
JP2016510323A5 (enExample)
JP2008513498A5 (enExample)
JP2009263394A5 (enExample)
JP2015501820A5 (enExample)
JP2013543842A5 (enExample)
MY165906A (en) Phenothiazine diaminium salts and their use
JP2012504133A5 (enExample)
JP2008255122A5 (enExample)
JP2012036221A5 (enExample)
CY1108752T1 (el) Παραγωγα πουρινης δρωντα ως αγωνιστες του α2α-υποδοχεα
RU2012112050A (ru) Производные дигидроптеридинона, способ их получения и фармацевтическое применение
JP2012530758A5 (enExample)
JP2011513410A5 (enExample)
JP2010155827A5 (enExample)
JP2010529994A5 (enExample)
JP2013525286A5 (enExample)
JP2005538111A5 (enExample)
JP2012509265A5 (enExample)